{"id":"https://openalex.org/W190357846","doi":"https://doi.org/10.1182/blood.v106.11.313.313","title":"A Randomized, Controlled Phase II Trial in Sickle Cell Disease Patients with Chronic Iron Overload Demonstrates That the Once-Daily Oral Iron Chelator Deferasirox (Exjade\u00ae, ICL670) Is Well Tolerated and Reduces Iron Burden.","display_name":"A Randomized, Controlled Phase II Trial in Sickle Cell Disease Patients with Chronic Iron Overload Demonstrates That the Once-Daily Oral Iron Chelator Deferasirox (Exjade\u00ae, ICL670) Is Well Tolerated and Reduces Iron Burden.","publication_year":2005,"publication_date":"2005-11-16","ids":{"openalex":"https://openalex.org/W190357846","doi":"https://doi.org/10.1182/blood.v106.11.313.313","mag":"190357846"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v106.11.313.313","doi":"https://doi.org/10.1182/blood.v106.11.313.313","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v106.11.313.313","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056946591","display_name":"Elliott P. Vichinsky","orcid":"https://orcid.org/0000-0002-0500-9579","observed_orcids":["https://orcid.org/0000-0002-0500-9579"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Vichinsky","raw_affiliation_strings":["Children\u2019s Hosp and Res Ctr, Oakland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s Hosp and Res Ctr, Oakland, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Fischer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Fischer","raw_affiliation_strings":["Children\u2019s Hosp and Res Ctr, Oakland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s Hosp and Res Ctr, Oakland, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053513542","display_name":"Ellen B. Fung","orcid":"https://orcid.org/0000-0003-0745-2598","observed_orcids":["https://orcid.org/0000-0003-0745-2598"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Fung","raw_affiliation_strings":["Children\u2019s Hosp and Res Ctr, Oakland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s Hosp and Res Ctr, Oakland, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110626270","display_name":"Onyinye C. Onyekwere","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137853757","display_name":"Howard University","ror":"https://ror.org/05gt1vc06","country_code":"US","type":"education","lineage":["https://openalex.org/I137853757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"O. Onyekwere","raw_affiliation_strings":["Howard Univ, Washington, USA","Howard University, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Howard Univ, Washington, USA","institution_ids":["https://openalex.org/I137853757"]},{"raw_affiliation_string":"Howard University, Washington, USA","institution_ids":["https://openalex.org/I137853757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049244658","display_name":"John B. Porter","orcid":"https://orcid.org/0000-0003-3000-9359","observed_orcids":["https://orcid.org/0000-0003-3000-9359"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Porter","raw_affiliation_strings":["Univ College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016083986","display_name":"Paul S. Swerdlow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Swerdlow","raw_affiliation_strings":["Karmanos Cancer Ctr, Detroit, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karmanos Cancer Ctr, Detroit, USA","institution_ids":["https://openalex.org/I4210090317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077729374","display_name":"Thomas D. Coates","orcid":"https://orcid.org/0000-0001-9878-6029","observed_orcids":["https://orcid.org/0000-0001-9878-6029"]},"institutions":[{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Coates","raw_affiliation_strings":["Children\u2019s Hosp of Los Angeles, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s Hosp of Los Angeles, USA","institution_ids":["https://openalex.org/I1336910626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108432642","display_name":"Peter A. Lane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Lane","raw_affiliation_strings":["Emory Univ, Atlanta, USA","Emory University, Atlanta, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory Univ, Atlanta, USA","institution_ids":["https://openalex.org/I150468666"]},{"raw_affiliation_string":"Emory University, Atlanta, USA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113815818","display_name":"Bea Files","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146983","display_name":"Children's Healthcare of Atlanta","ror":"https://ror.org/050fhx250","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146983"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Files","raw_affiliation_strings":["Children\u2019s Healthcare, Atlanta, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s Healthcare, Atlanta, USA","institution_ids":["https://openalex.org/I4210146983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025036510","display_name":"Brigitta Ursula Mueller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. U. Mueller","raw_affiliation_strings":["Baylor College of Medicine, Houston, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine, Houston, France","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033760104","display_name":"Fran\u00e7oise Bernaudin","orcid":"https://orcid.org/0000-0001-5184-8288","observed_orcids":["https://orcid.org/0000-0001-5184-8288"]},"institutions":[{"id":"https://openalex.org/I4210159273","display_name":"H\u00f4pital Intercommunal de Cr\u00e9teil","ror":"https://ror.org/04n1nkp35","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210159273"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F. Bernaudin","raw_affiliation_strings":["Centre Hospitalier Intercommunal, Creteil, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Hospitalier Intercommunal, Creteil, France","institution_ids":["https://openalex.org/I4210159273"]}]},{"author_position":"middle","author":{"id":null,"display_name":"G. L. Forni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018768319","display_name":"Ente Ospedaliero Ospedali Galliera","ror":"https://ror.org/05bs6ak67","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I3018768319","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. L. Forni","raw_affiliation_strings":["Ospedale Galliera, Genoa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ospedale Galliera, Genoa, Italy","institution_ids":["https://openalex.org/I3018768319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037220376","display_name":"Catherine Ressayre-Djaffer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Ressayre-Djaffer","raw_affiliation_strings":["Novartis, East Hanover, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis, East Hanover, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085532556","display_name":"Insa Gathmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"I. Gathmann","raw_affiliation_strings":["Novartis, East Hanover, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis, East Hanover, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065729832","display_name":"Jaymes S. Holland","orcid":"https://orcid.org/0009-0004-0532-1740","observed_orcids":["https://orcid.org/0009-0004-0532-1740"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Holland","raw_affiliation_strings":["Novartis, East Hanover, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis, East Hanover, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110414483","display_name":"D. Alberti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Alberti","raw_affiliation_strings":["Novartis, East Hanover, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis, East Hanover, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000410098","display_name":"Peter W Marks","orcid":"https://orcid.org/0000-0001-5619-4404","observed_orcids":["https://orcid.org/0000-0001-5619-4404"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Marks","raw_affiliation_strings":["Novartis, East Hanover, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis, East Hanover, USA","institution_ids":["https://openalex.org/I4210117619"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":2.072,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.88231544,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"106","issue":"11","first_page":"313","last_page":"313"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":0.996999979019165},{"id":"https://openalex.org/keywords/chronic-iron-overload","display_name":"chronic iron overload","score":0.9779999852180481},{"id":"https://openalex.org/keywords/deferasirox","display_name":"deferasirox","score":0.9679999947547913},{"id":"https://openalex.org/keywords/deferoxamine","display_name":"deferoxamine","score":0.9419999718666077},{"id":"https://openalex.org/keywords/oral-iron-chelation","display_name":"oral iron chelation","score":0.9580000042915344},{"id":"https://openalex.org/keywords/liver-iron-concentration","display_name":"liver iron concentration","score":0.9200000166893005},{"id":"https://openalex.org/keywords/serum-ferritin","display_name":"serum ferritin","score":0.8159999847412109},{"id":"https://openalex.org/keywords/iron-balance","display_name":"iron balance","score":0.7390000224113464},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7609999775886536},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.6290000081062317},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4410000145435333},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.47600001096725464},{"id":"https://openalex.org/keywords/iron-chelation-therapy","display_name":"iron chelation therapy","score":0.3230000138282776}],"concepts":[{"id":"https://openalex.org/C2781053155","wikidata":"https://www.wikidata.org/wiki/Q5251502","display_name":"Deferasirox","level":3,"score":0.9542429447174072},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7103787660598755},{"id":"https://openalex.org/C2776672577","wikidata":"https://www.wikidata.org/wiki/Q419618","display_name":"Deferoxamine","level":2,"score":0.6642866134643555},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6503323912620544},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5816168785095215},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5357401371002197},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5262707471847534},{"id":"https://openalex.org/C2776517179","wikidata":"https://www.wikidata.org/wiki/Q749664","display_name":"Deferiprone","level":3,"score":0.4565436840057373},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.4532438814640045},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.42735540866851807},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4210774898529053},{"id":"https://openalex.org/C2777799968","wikidata":"https://www.wikidata.org/wiki/Q185137","display_name":"Thalassemia","level":2,"score":0.36782607436180115}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v106.11.313.313","doi":"https://doi.org/10.1182/blood.v106.11.313.313","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v106.11.313.313","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2594652814","https://openalex.org/W4255257391","https://openalex.org/W2553536515","https://openalex.org/W1995812599","https://openalex.org/W2554055446","https://openalex.org/W2559580547","https://openalex.org/W1911216300","https://openalex.org/W7052100343","https://openalex.org/W2992122126","https://openalex.org/W1747646164"],"abstract_inverted_index":{"Abstract":[0],"Repeated":[1],"blood":[2],"transfusion":[3],"to":[4,84,98,105,273,373,431,442,456,460],"prevent":[5],"complications":[6],"places":[7],"patients":[8,76,259,371,468],"with":[9,23,87,221,278,410,421,469],"sickle":[10,470],"cell":[11,471],"disease":[12],"at":[13,28,415],"risk":[14],"for":[15,349,352],"morbidity":[16],"from":[17,96,103,143,346],"chronic":[18],"iron":[19,30,43,113,168,203,323,429,432,446,464],"overload.":[20],"Parenteral":[21],"chelation":[22],"deferoxamine":[24],"(DFO)":[25],"is":[26,35,40,451],"effective":[27],"reducing":[29,463],"overload":[31],"but":[32],"patient":[33,263],"compliance":[34],"generally":[36,224],"poor.":[37],"Deferasirox":[38],"(DSX)":[39],"an":[41,267,384],"investigational":[42],"chelator":[44],"given":[45,191],"orally":[46],"once-daily.":[47],"Demonstration":[48],"of":[49,54,70,94,187,228,246,253,355,364,390,417,428,434],"the":[50,61,71,137,174,250,408,413,422],"safety":[51],"and":[52,64,74,101,156,167,176,189,196,201,209,226,234,248,336,357,378,395,454],"tolerability":[53],"DSX":[55,88,95,129,145,175,188,222,265,292,294,335,356,375,439,450],"over":[56],"a":[57,67,122,340],"1-year":[58],"period":[59],"was":[60,66,108,159,205,339,359,369,419,440],"primary":[62],"objective":[63,69],"efficacy":[65,459],"secondary":[68],"study.":[72],"Adult":[73],"pediatric":[75],"(n=195;":[77],"n=98":[78],"aged":[79],"<16)":[80],"were":[81,133,171,192,223,255],"randomized":[82],"2:1":[83],"receive":[85,374],"treatment":[86],"(n=132)":[89],"or":[90],"DFO":[91,102,177,190,293,295,337,358,379,461],"(n=63).":[92],"Dosing":[93],"5":[97],"30":[99,376],"mg/kg/day":[100,107,282],"20":[104],"60":[106],"based":[109,139],"upon":[110,140],"baseline":[111,247,347],"liver":[112,119],"concentration":[114],"(LIC)":[115],"as":[116],"determined":[117],"by":[118,161],"susceptometry":[120],"using":[121],"superconducting":[123],"quantum":[124],"interference":[125],"device":[126],"(SQUID).":[127],"Initial":[128],"doses":[130,186],"<20":[131],"mg/kg":[132,377,382],"increased":[134],"midway":[135],"through":[136],"trial":[138,409],"emerging":[141],"data":[142],"other":[144],"trials.":[146],"Safety":[147],"assessments":[148],"included":[149],"hematology,":[150],"chemistry,":[151],"eye":[152],"exams,":[153],"hearing":[154],"tests":[155],"ECGs.":[157],"Efficacy":[158,354],"measured":[160],"LIC,":[162],"change":[163,297,312,386],"in":[164,173,240,257,344,387,462,466],"serum":[165,241,388,404],"ferritin,":[166],"balance.":[169,447],"Discontinuations":[170],"similar":[172,360,458],"groups":[178],"(11.4":[179],"vs":[180],"11.1%).":[181],"The":[182,215,426],"mean":[183],"\u00b1":[184,194,198,207,211,286,290,303,307,316,320,327,331,392,397],"SD":[185,287,291],"17.3":[193],"6.0":[195],"36.0":[197],"11.4":[199],"mg/kg,":[200],"transfusional":[202],"intake":[204,433],"0.21":[206],"0.13":[208],"0.23":[210],"0.12":[212],"mg/kg/day,":[213],"respectively.":[214,402],"most":[216,270],"common":[217],"adverse":[218],"events":[219],"associated":[220],"mild":[225],"consisted":[227],"nausea,":[229],"vomiting,":[230],"diarrhea,":[231],"abdominal":[232],"pain":[233],"skin":[235],"rash.":[236],"Mild":[237],"non-progressive":[238],"increases":[239],"creatinine":[242],"greater":[243],"than":[244],"33%":[245],"above":[249],"upper":[251],"limit":[252],"normal":[254],"observed":[256],"three":[258],"receiving":[260],"DSX.":[261],"One":[262],"on":[264,424],"developed":[266],"elevated":[268],"ALT":[269],"likely":[271],"related":[272],"drug":[274],"administration":[275],"that":[276,438],"resolved":[277],"its":[279],"discontinuation.":[280],"Median":[281],"Parameter":[283],"n":[284,288],"Mean":[285,289],"LIC":[296,345],"(mg":[298],"Fe/g":[299],"dw)":[300],"113":[301],"\u22121.3":[302],"3.1":[304],"54":[305],"\u22120.7":[306],"2.6":[308],"16.7":[309],"32.7":[310],"Ferritin":[311],"(\u03bcg/L)":[313],"83":[314],"\u2212183":[315],"1651":[317],"33":[318],"\u2212558":[319],"951":[321],"Ratio":[322],"excretion/intake":[324],"105":[325],"1.14":[326],"0.60":[328],"52":[329],"1.20":[330],"0.78":[332],"With":[333],"both":[334,411],"there":[338],"statistically":[341],"significant":[342],"reduction":[343,414],"(P<0.0001":[348],"DSX,":[350],"P=0.022":[351],"DFO).":[353],"after":[361],"1":[362],"year":[363],"therapy.":[365],"A":[366],"dose-effect":[367],"relationship":[368],"observed:":[370],"assigned":[372],"\u2265":[380],"50":[381],"had":[383],"absolute":[385],"ferritin":[389,405],"\u22121196":[391],"2674":[393],"(n=10)":[394],"\u2212936":[396],"1115":[398],"\u03bc":[399],"g/L":[400],"(n=7),":[401],"Although":[403],"varied":[406],"during":[407],"treatments,":[412],"end":[416],"study":[418],"consistent":[420],"effect":[423],"LIC.":[425],"ratio":[427],"excretion":[430],">1":[435],"also":[436],"indicates":[437],"able":[441],"induce":[443],"negative":[444],"body":[445],"Once-daily":[448],"oral":[449],"well":[452],"tolerated":[453],"appears":[455],"have":[457],"burden":[465],"transfused":[467],"disease.":[472]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2016-06-24T00:00:00"}